Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

ELISA test validated for serotonin metabolite measuring
The ELISA test would be more widely available to vets.
The test can measure for the metabolite in dogs’ urine.

A new study has validated the use of a commercially available test to measure the metabolite of serotonin in the urine of dogs.

When measured against the current ‘gold standard’ test, the ELISA test proved precise at measuring for 5-hydroxyindoleacetic acid (5-HIAA).

Researchers from the Queen’s Veterinary School Hospital, at the University of Cambridge, assessed urine samples from 26 dogs undergoing routine diagnostic evaluation at a referral hospital. The samples were then analysed with both the ELISA testing kit and the liquid chromatography-tandem mass spectrometry (LC-MS).

The results revealed the ELISA test to be reliable, with an acceptable level of precision and availability. However, while it was particularly precise at low concentrations of 5-HIAA, researchers did note a slightly higher observed error at higher concentrations.

The team concluded that the ELISA test was a more accessible, less invasive and relatively low-cost method for assessing 5-HIAA in dogs.

Researchers have called for further validation work on the test, addressing the preanalytical factors which may influence the measurement of concentrations. It also advises investigation into whether measuring urinary 5-HIAA is a good surrogate marker for physiologically active circulating serotonin in dogs.

Dr Penny Watson, senior author of the study, said: “I am very hopeful that, after further validation, this ELISA will prove to be a reliable, simple and cheap test for 5-HIAA in the urine, facilitating further research into the role of serotonin in the pathogenesis of canine diseases.

“We have long suspected that some individual dogs and breeds may have higher circulating serotonin than others and that this might predispose them not only to heart disease but also some common diseases such as chronic pancreatitis and kidney disease. They would also be more susceptible to serotinergic syndrome when medicated with drugs such as tramadol or trazadone. Further research in this area would thus be directly relevant to small animal practitioners.”

The full study can be found in the Journal of Small Animal Practice.

Image © Liudmila Bohush/Shutterstock

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.